Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
23.61
+1.32 (5.90%)
At close: Mar 5, 2026, 4:00 PM EST
23.70
+0.09 (0.40%)
After-hours: Mar 5, 2026, 4:10 PM EST
KMTS Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for KMTS stock have an average target of 28.67, with a low estimate of 25 and a high estimate of 32. The average target predicts an increase of 21.46% from the current stock price of 23.61.
Analyst Consensus: Buy
* Price targets were last updated on Dec 15, 2025.
Analyst Ratings
The average analyst rating for KMTS stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Maintains $22 → $25 | Hold | Maintains | $22 → $25 | +5.91% | Dec 15, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $27 → $28 | Buy | Maintains | $27 → $28 | +18.62% | Dec 12, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $27 → $30 | Buy | Maintains | $27 → $30 | +27.09% | Dec 12, 2025 |
| BTIG | BTIG | Strong Buy Initiates $32 | Strong Buy | Initiates | $32 | +35.56% | Nov 18, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $28 → $27 | Buy | Maintains | $28 → $27 | +14.38% | Jul 17, 2025 |
Financial Forecast
Revenue This Year
92.76M
from 59.82M
Increased by 55.07%
Revenue Next Year
92.77M
from 92.76M
Increased by 0.01%
EPS This Year
-2.36
from -5.13
EPS Next Year
-2.35
from -2.36
Revenue Forecast
| Revenue | 2026 | 2026 | 2027 | 2027 | 2028 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|
| High | 96.1M | 96.1M | |||||
| Avg | 92.8M | 92.8M | |||||
| Low | 88.5M | 88.5M |
Revenue Growth
| Revenue Growth | 2026 | 2026 | 2027 | 2027 | 2028 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|
| High | 60.6% | 3.6% | |||||
| Avg | 55.1% | 0.0% | |||||
| Low | 48.0% | -4.6% |
EPS Forecast
| EPS | 2026 | 2026 | 2027 | 2027 | 2028 | 2028 |
|---|---|---|---|---|---|---|
| High | -2.43 | -2.34 | ||||
| Avg | -2.36 | -2.35 | ||||
| Low | -2.27 | -2.33 |
EPS Growth
| EPS Growth | 2026 | 2026 | 2027 | 2027 | 2028 | 2028 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.